生物活性 靶点 体外研究 体内研究 869185-85-3 试剂级价格
ChemicalBook  CAS数据库列表  869185-85-3

869185-85-3

869185-85-3,869185-85-3,结构式
869185-85-3
  • CAS号:869185-85-3
  • 英文名:SB 203580 (hydrochloride)
  • 中文名:869185-85-3
  • CBNumber:CB52592405
  • 分子式:C21H17ClFN3OS
  • 分子量:413.9
  • MOL File:869185-85-3.mol
869185-85-3化学性质
  • 储存条件 :-20C
  • 溶解度 :insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL in DMSO
  • 形态 :Bright yellow solid
  • 颜色 :Light yellow to yellow
  • 水溶解性 :Soluble to 25 mM in water
  • 稳定性 :Hygroscopic
安全信息
  • 海关编码 :2933399990

869185-85-3性质、用途与生产工艺

  • 生物活性 SB 203580 hydrochloride (RWJ 64809 hydrochloride) 是一种选择性的,ATP 竞争性的 p38 MAPK 抑制剂,对 SAPK2a/p38 和 SAPK2b/p38β2 的 IC50 分别为 50 nM 和 500 nM。SB 203580 hydrochloride 抑制 LCK,GSK3β 和 PKBα,IC50 比 SAPK2a/p38 高 100-500 倍。SB 203580 hydrochloride 是一种自噬 (autophagy) 和有丝分裂 (mitophagy) 激活剂。
  • 靶点

    p38

    50 nM (IC 50 )

    p38β2

    500 nM (IC 50 )

  • 体外研究

    SB 203580 (preincubated with 0-30 μM for 1 h and cultured for 24 h in the presence of 20 ng/mL IL-2) prevents the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC 50 of 3-5 μM.
    SB203580 blocks PKB phosphorylation (IC 50 3-5 μM). SB203580 inhibitsthe phosphorylation of Ser473 in a dose-dependent manner in both CT6 and activated human T cells and IL-2-responsive BA/F3 F7 B cells.

    Cell Proliferation Assay

    Cell Line: CT6, BA/F3 cell line F7, and PBMC/T cells
    Concentration: 0-30 μM
    Incubation Time: Preincubated with 0-30 μM SB203580 for 1 h and cultured for 24 h in the presence of 20 ng/mL IL-2
    Result: Prevented the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC 50 of 3-5 μM.

    Western Blot Analysis

    Cell Line: CT6 cells, activated human T cells, and BA/F3 F7 cells
    Concentration: 0-30 μM
    Incubation Time: Preincubated with 0-30 μM SB203580 for 1 h before stimulating with 20 ng/mL IL-2 for 5 min
    Result: Inhibited the phosphorylation of PKB at Ser473 in a dose-dependent manner.
  • 体内研究

    SB203580 (5 mg/kg/day; intra peritoneal injected daily for 16 consecutive days, in female atymic Nu/Nu mice) treatment, p38WT tumors show a significantly smaller tumor burden when compared with p38TM tumors that were treated in parallel.

    Animal Model: Six-week-old female atymic Nu/Nu mice CAL27 p38WT and p38TM tumors
    Dosage: 5 mg/kg/day
    Administration: Intra peritoneal injected daily for 16 consecutive days
    Result: After 2 weeks treatment, CAL27 p38WT tumors were significantly smaller; CAL27 p38TM tumors were not affected by the p38 inhibitor (n=10).
869185-85-3上下游产品信息
上游原料
下游产品
869185-85-3 试剂级价格
  • 更新日期:2024/11/08
  • 产品编号:HY-10256A
  • 产品名称:Adezmapimod hydrochloride
  • CAS编号:
  • 包装:5 mg
  • 价格:330元
  • 更新日期:2024/11/08
  • 产品编号:HY-10256A
  • 产品名称:869185-85-3 Adezmapimod hydrochloride
  • CAS编号:869185-85-3
  • 包装:10mM * 1mLin DMSO
  • 价格:363元
869185-85-3生产厂家
  • 公司名称:TOCRIS-US
  • 联系电话:--
  • 电子邮件:customerservice@tocris.co.uk
  • 国家:英国
  • 产品数:5726
  • 优势度:77
869185-85-3, 869185-85-3相关搜索: